Habermeyer, Johanna
Boyken, Janina
Harrer, Julia
Canneva, Fabio
Ratz, Veronika
Moceri, Sandra
Admard, Jakob
Casadei, Nicolas
Jost, Gregor
Bäuerle, Tobias
Frenzel, Thomas
Schmitz, Christoph
Schütz, Gunnar
Pietsch, Hubertus
von Hörsten, Stephan http://orcid.org/0000-0001-6409-0664
Funding for this research was provided by:
Bayer
Projekt DEAL
Article History
Received: 16 August 2020
Accepted: 1 December 2020
First Online: 28 December 2020
Competing interests
: J.B., G.J., T.F., G.S. and H.P. are employees of Bayer AG, holding marketing authorization for gadobutrol. For the remaining authors, no conflicts of interest are declared. This study has been partially funded by Bayer AG.